HK1206363A1 - μ-阿片受體肽的有益鹽 - Google Patents
μ-阿片受體肽的有益鹽Info
- Publication number
- HK1206363A1 HK1206363A1 HK15106792.0A HK15106792A HK1206363A1 HK 1206363 A1 HK1206363 A1 HK 1206363A1 HK 15106792 A HK15106792 A HK 15106792A HK 1206363 A1 HK1206363 A1 HK 1206363A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- opiate receptor
- receptor peptides
- advantageous salts
- salts
- advantageous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US761707P | 2007-12-13 | 2007-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206363A1 true HK1206363A1 (zh) | 2016-01-08 |
Family
ID=40755912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106792.0A HK1206363A1 (zh) | 2007-12-13 | 2015-07-16 | μ-阿片受體肽的有益鹽 |
Country Status (8)
Country | Link |
---|---|
US (6) | US20110190214A1 (zh) |
EP (2) | EP2229400B1 (zh) |
JP (1) | JP5647002B2 (zh) |
AU (1) | AU2008334941B2 (zh) |
CA (2) | CA2984218C (zh) |
ES (1) | ES2550604T3 (zh) |
HK (1) | HK1206363A1 (zh) |
WO (1) | WO2009076672A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110065648A1 (en) * | 2009-09-15 | 2011-03-17 | Maione Theodore E | Advantageous mu-opiate receptor peptide compounds |
WO2011146922A2 (en) * | 2010-05-21 | 2011-11-24 | Cytogel Pharma, Llc | Materials and methods for treatment of inflammation |
US20150126455A1 (en) * | 2012-05-18 | 2015-05-07 | Cytogel Pharma, Llc. | Novel Therapeutic Uses of Mu-Opiate Receptor Peptides |
AU2018284219A1 (en) * | 2017-06-12 | 2020-01-16 | Board Of Regents Of The University Of Nebraska | Hydrochloride salts of C5a receptor agonist peptides |
US10975121B2 (en) | 2017-06-24 | 2021-04-13 | Cytogel Pharma, Llc | Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof |
US20200270304A1 (en) * | 2017-11-17 | 2020-08-27 | Cytogel Pharma, Llc | Polymer agonists of mu opioid receptors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235496B1 (en) * | 1993-03-08 | 2001-05-22 | Advanced Research & Technology Institute | Nucleic acid encoding mammalian mu opioid receptor |
US5942492A (en) * | 1996-11-12 | 1999-08-24 | Angstrom Pharmaceuticals, Inc. | Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
US5885958A (en) * | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
JPH10330398A (ja) * | 1997-05-28 | 1998-12-15 | Asahi Glass Co Ltd | 新規環状ペプチド |
SE9800865D0 (sv) * | 1998-03-16 | 1998-03-16 | Astra Ab | New Process |
JPWO2002102833A1 (ja) * | 2001-06-15 | 2004-09-30 | 千寿製薬株式会社 | 新規エンドモルフィン誘導体 |
EP1427438A2 (en) | 2001-09-03 | 2004-06-16 | The University of Bristol | Inflammation modulatory compound comprising an endomorphin |
US6936718B2 (en) * | 2001-11-29 | 2005-08-30 | Schering Corporation | Preparation of rotamer mixtures of pharmaceutical salts |
-
2008
- 2008-12-15 AU AU2008334941A patent/AU2008334941B2/en not_active Ceased
- 2008-12-15 ES ES14189232.3T patent/ES2550604T3/es active Active
- 2008-12-15 JP JP2010538227A patent/JP5647002B2/ja not_active Expired - Fee Related
- 2008-12-15 CA CA2984218A patent/CA2984218C/en not_active Expired - Fee Related
- 2008-12-15 CA CA2707733A patent/CA2707733C/en not_active Expired - Fee Related
- 2008-12-15 EP EP08858817.3A patent/EP2229400B1/en not_active Not-in-force
- 2008-12-15 WO PCT/US2008/086838 patent/WO2009076672A1/en active Application Filing
- 2008-12-15 EP EP14189232.3A patent/EP2826786B1/en active Active
- 2008-12-15 US US12/744,859 patent/US20110190214A1/en not_active Abandoned
-
2013
- 2013-10-17 US US14/056,496 patent/US8940704B2/en active Active
-
2014
- 2014-12-15 US US14/570,432 patent/US20150152137A1/en not_active Abandoned
-
2015
- 2015-07-16 HK HK15106792.0A patent/HK1206363A1/zh unknown
-
2018
- 2018-06-22 US US16/016,165 patent/US20180291060A1/en not_active Abandoned
-
2020
- 2020-07-15 US US16/929,994 patent/US20200339628A1/en not_active Abandoned
-
2021
- 2021-12-17 US US17/554,421 patent/US20220324908A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2008334941A1 (en) | 2009-06-18 |
US20150152137A1 (en) | 2015-06-04 |
EP2229400A1 (en) | 2010-09-22 |
US20140142050A1 (en) | 2014-05-22 |
WO2009076672A1 (en) | 2009-06-18 |
CA2707733C (en) | 2018-01-02 |
US20200339628A1 (en) | 2020-10-29 |
JP5647002B2 (ja) | 2014-12-24 |
CA2984218C (en) | 2019-12-31 |
US8940704B2 (en) | 2015-01-27 |
US20220324908A1 (en) | 2022-10-13 |
US20110190214A1 (en) | 2011-08-04 |
CA2707733A1 (en) | 2009-06-18 |
CA2984218A1 (en) | 2009-06-18 |
US20180291060A1 (en) | 2018-10-11 |
EP2826786A1 (en) | 2015-01-21 |
JP2011508727A (ja) | 2011-03-17 |
EP2229400A4 (en) | 2012-01-04 |
EP2229400B1 (en) | 2014-11-19 |
ES2550604T3 (es) | 2015-11-11 |
AU2008334941B2 (en) | 2013-02-14 |
EP2826786B1 (en) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2244575A4 (en) | ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR | |
EP2242505A4 (en) | GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES | |
ZA201001597B (en) | Octahydropentalene compounds as chemokine receptor antagonists | |
EP2427430A4 (en) | 5-OXO-ETE RECEPTOR ANTAGONIST COMPOUNDS | |
HK1206363A1 (zh) | μ-阿片受體肽的有益鹽 | |
EP2034832A4 (en) | IL-8 RECEPTOR ANTAGONIST | |
EP2362779A4 (en) | CXCR4 RECEPTOR COMPOUNDS | |
IL196587A0 (en) | 2-phenyl-indoles as prostaglandin d2 receptor antagonists | |
HK1160642A1 (zh) | 用作加壓素 受體拮抗劑的二氫四氮雜苯並薁的芳基環己基醚 | |
IL217526A0 (en) | Carbocyclic glyt1 receptor antagonists | |
GB0723712D0 (en) | Peptides | |
IL216086A0 (en) | Peptide ligands of somatostatin receptors | |
IL197979A0 (en) | Method for peptide synthesis | |
EP2478001A4 (en) | BENEFICIAL PEPTIDE COMPOUNDS OF MU OPIACEOUS RECEPTOR | |
EP2123666A4 (en) | PEPTIDE | |
GB0724953D0 (en) | Methods of peptide modification | |
IL193427A0 (en) | Polypeptide antagonist | |
EP2250168A4 (en) | ANTAGONISTS OF ANGIOTENSIN II RECEPTORS | |
IL207438A0 (en) | 2-aminoquinolines as 5-ht5a receptor antagonists | |
EP2188305A4 (en) | MODIFIED PEPTIDES HAVING TOXIN IMPROVING EFFECTS | |
GB0703945D0 (en) | Peptide | |
EP2411813A4 (en) | NEW RECEPTOR HETERO DIMERS / OLIGOMERS | |
EP2291076A4 (en) | Angiotensin-II Receptor Antagonists | |
GB0812586D0 (en) | Chimaeric peptide | |
ZA200810564B (en) | 2-phenyl-indoles as prostaglandin D2 receptor antagonists |